Top 25 Health Care Angel Investors in Belgium in April 2025
A list of 25 angel investors that invest in Health care startups based in Belgium. We rank investors based on the number of investments they made in Health care companies from Belgium. We update this investor list every month.Top 25 Health Care Angel Investors in Belgium in April 2025
Investor | Health Care Belgium investments |
---|---|
Annie Vereecken | 4 |
Pierre Rigaux | 4 |
Pierre Drion | 3 |
Louis Jonckheere | 1 |
Matthias Geeroms | 1 |
georges verpraet | 1 |
Jurgen De Baerdemaeker | 1 |
Yves Berquin | 1 |
Annemie Van de Casteele | 1 |
David Prior | 1 |
Eyal Gura | 1 |
Jean Dessain | 1 |
Virginie Saverys | 1 |
Eduardo Ronzano | 1 |
Kenneth Buckfire | 1 |
Patrick Keereman | 1 |
Konstantin Mehl | 1 |
Yves Beudin | 1 |
Herman Verrelst | 1 |
Eric Janvier | 1 |
Griet Nuytinck | 1 |
Manuel Thurner | 1 |
Jeroen De Wit | 1 |
Evren Ucok | 1 |
Joris Van Der Gucht | 1 |
Annie Vereecken
Show more
Investment focus
- Biotechnology, Medical, Hospital
- Seed, Series A, Funding Round
- Belgium
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Pierre Rigaux
Show more
Investment focus
- Sports, Medical Device
- Seed, Pre-Seed, Convertible Note
- Belgium
Portfolio highlights
- MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
Pierre Drion - CEO @ Petercam
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Funding Round
- Belgium
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — This is the homepage of the website
Louis Jonckheere is the Co-Founder and Board member at In The Pocket. Louis Jonckheere attended Vlerick Business School.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Series A, Pre-Seed
- Belgium, France
Portfolio highlights
- Henchman — Effortlessly find the clauses you’re looking for by applying our AI to your existing contracts.
- IntelliProve — Supercharge your digital health solution with clinically-validated biomarker data from sophisticated facial scanning technology.
- Predikt — Predikt empowers finance leaders to navigate today’s volatile markets with clarity and confidence. By integrating advanced AI, external market data, and internal financial metrics, Predikt transforms forecasting into a strategic advantage.Our pioneering Confidence Intelligence platform:- Provides transparency and automation to reduceforecasting uncertainty. - Enables CFOs to assess risks, identify opportunities, and align teams globally. - Turns data into decisions that foster resilience and drive growth.We understand the challenges finance leaders face: juggling a high-level view with local market complexities. That’s why Predikt is designed to enhance collaboration, challenge assumptions, and provide confidence in every number.Founded by a Swiss-Belgian team in 2023, Predikt is democratizing predictive technology, equipping finance teams to make smarter decisions and thrive amid uncertainty.
Matthias Geeroms Co-Founded Social Significance Ltd. in 2012 and serves as its Chief Financial Officer. Matthias Geeroms has a background in finance and legal. Prior to founding OTA Insight he worked with different multinational Fortune 500 companies auditing their business and transfer pricing setup. He is in charge of all customer billing, legaland compliance activities.
Show more
Investment focus
- Software, Artificial Intelligence, CRM
- Pre-Seed, Seed
- Belgium
Portfolio highlights
- Jurimesh — Jurimesh streamlines legal due diligence with automated red-flag detection, tailored recommendations, and detailed DD reports, empowering legal teams with insights and efficiency for every transaction.
- IntelliProve — Supercharge your digital health solution with clinically-validated biomarker data from sophisticated facial scanning technology.
- Predikt — Predikt empowers finance leaders to navigate today’s volatile markets with clarity and confidence. By integrating advanced AI, external market data, and internal financial metrics, Predikt transforms forecasting into a strategic advantage.Our pioneering Confidence Intelligence platform:- Provides transparency and automation to reduceforecasting uncertainty. - Enables CFOs to assess risks, identify opportunities, and align teams globally. - Turns data into decisions that foster resilience and drive growth.We understand the challenges finance leaders face: juggling a high-level view with local market complexities. That’s why Predikt is designed to enhance collaboration, challenge assumptions, and provide confidence in every number.Founded by a Swiss-Belgian team in 2023, Predikt is democratizing predictive technology, equipping finance teams to make smarter decisions and thrive amid uncertainty.
georges verpraet
Show more
Investment focus
- Medical, Health Care, Information Technology
- Seed
- Belgium
Portfolio highlights
- Salvus Health — Salvus Health is het platform voor preventieve en farmaceutische diensten in de apotheek.
Jurgen De Baerdemaeker
Show more
Investment focus
- Medical, Health Care, Information Technology
- Seed
- Belgium
Portfolio highlights
- Salvus Health — Salvus Health is het platform voor preventieve en farmaceutische diensten in de apotheek.
Yves Berquin is the Co-Founder and Co-CEO of Matrix Requirements. He attended Free University of Brussels.
.
Show more
Investment focus
- Medical, Health Care, Information Technology
- Seed
- Belgium
Portfolio highlights
- Salvus Health — Salvus Health is het platform voor preventieve en farmaceutische diensten in de apotheek.
Annemie Van de Casteele is a former member of the Belgian Parliament.
Show more
Investment focus
- Medical, Life Science, Biotechnology
- Seed
- Belgium
Portfolio highlights
- 4Tissue — Shaping the Future of Regenerative Medicine
David Prior is the former chair of the UK's National Health Service.
Show more
Investment focus
- Health Care, Medical, Software
- Seed
- Belgium, United Kingdom
Portfolio highlights
- TORTUS AI — Innovative medical AI which revolutionises the healthcare industry by enhancing clinical operations and patient care. Book a free demo today.
- Awell Health — Ollie is a vast library of over 100 interface blocks with complete Webflow CMS integration. Build beautiful websites in less time than ever.
Eyal Gura is the Board Member of Imagene AI. He previously worked at Zebra Medical Vision Ltd as a Co-Founder, President and Chairman of the Board. Eyal Gura attended Reichman University (IDC Herzliya).
Show more
Investment focus
- Software, Mobile, Artificial Intelligence
- Series A, Seed, Series B
- United States, Israel, Belgium
Portfolio highlights
- Theator — Discover the world's first surgical intelligence platform from theator. Continually perfect your craft with AI & computer vision technology.
- Taranis — Taranis offers cutting-edge crop & farm management software for precision agriculture. Increase efficiency and yield. Learn more now.
- Imagene AI — Imagene is a pioneering company in AI-powered Oncology Intelligence dedicated to decoding cancer using biopsy images.
Jean Dessain - Non Executive Director @ OneLIFE
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Virginie Saverys is a entrepreneur.
Show more
Investment focus
- Medical, Life Science, Biotechnology
- Seed
- Belgium
Portfolio highlights
- 4Tissue — Shaping the Future of Regenerative Medicine
Eduardo Ronzano is the Co-Founder and CEO of Kolet. He previously worked at The Bradery as a Pre-Seed Investor. Eduardo Ronzano attended ESCP Business School.
Show more
Investment focus
- Software, SaaS, E-Commerce
- Seed, Pre-Seed, Angel
- France, United States, United Kingdom
Portfolio highlights
- Screeb — Make products your users will love by using Screeb, the all-in-one tool for Product Discovery. Product analytics, user recruitment, and more!
- Frak Labs — Manage your unified web identity, earn rewards, and interact seamlessly with partner websites using our passkey-first blockchain smart wallet.
- Poolside — The best code you never wrote.
Kenneth Buckfire is the Chief Executive Officer at Miller Buckfire.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Belgium
Portfolio highlights
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Patrick Keereman
Show more
Investment focus
- Medical, Hardware, Software
- Seed
- Belgium
Portfolio highlights
- MOLECUBES — MOLECUBES is a Ghent University spin-off started with the support of iMinds. Springing from the MEDISIP research group and the preclinical INFINITY lab, a team of young hardware and software engineers with hands-on experience grouped together to make a difference in their and your daily imaging practice.We build preclinical imaging cubesallowing you to combine SPECT, PET and CT imaging in almost any lab space. Modular systems leave full flexibility at your side while ensuring full mice and full rat imaging. Intuitive wireless acquisition and reconstruction software allow the systems to be used almost anywhere by anyone. Being built by end-users we also understand the importance of good servicing.
Konstantin Mehl is the President, CEO, and founder of Kaia Health. Konstantin is a serial entrepreneur. His last company foodora, a global food delivery company was sold to delivery hero in 2015 after reaching 500 employees and 5,000 drivers. His current company Kaia has the mission to build the biggest platform for chronic disease management,powered by computer vision. His angel investments include more than 20 companies in the US and Europe. He holds a dual Masters from Columbia University and a Bachelors degree from Technical University Munich.
Show more
Investment focus
- iOS, Banking, Security
- Pre-Seed, Seed
- Germany, Belgium, United States
Yves Beudin
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Herman Verrelst
Show more
Investment focus
- Medical, Hospital, Biotechnology
- Series A
- Belgium
Portfolio highlights
- UgenTec — FastFinder is intelligent software that automates sample workflow, ensures your assays are analyzed consistently and cuts data analysis time in half.
Eric Janvier
Show more
Investment focus
- Medical, Health Care
- Series A
- Belgium
Portfolio highlights
- Elysia — Elysia developed solution dedicated to quality control laboratories for the production of Radio Pharmaceuticals.
Griet Nuytinck is founder of Anacura.
Show more
Investment focus
- Medical, Life Science, Biotechnology
- Seed
- Belgium
Portfolio highlights
- 4Tissue — Shaping the Future of Regenerative Medicine
Manuel Thurner is the Co-Founder and Co-CEO at Kaia Health. He attended the Technical University of Munich, Massachusetts Institute of Technology, and Center for Digital Technology and Management, CDTM.
Show more
Investment focus
- iOS, Software, Navigation
- Pre-Seed, Seed
- Germany, Belgium
Portfolio highlights
- OCELL — Building the Operating System of Sustainable Forestry
- AYES — AYES provides the leading AI service to create accessible mobility for blind and visually impaired people.
- Kranus Health — Kranus Health is a global provider for Men‘s Health Prescription Digital Therapeutics (PDTs). Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.
Jeroen De Wit is CEO and co-founder of Teamleader, a Belgian scale-up that offers an all-in-one software solution for Customer Relationship Management (CRM), invoicing and project management to SMEs. The main idea? Helping SMEs and young startups work smarter, and focus on what matters. Jeroen is a passionate entrepreneur, driven by an iron willand the desire to really help other businesses.
Show more
Investment focus
- Artificial Intelligence, CRM, Legal
- Pre-Seed, Seed
- Belgium
Portfolio highlights
- Donna — Meet Donna, your AI-powered sales assistant designed to streamline your sales process. Reduce admin tasks, automate CRM updates, and draft follow-up emails with ease. Spend more time closing deals and less on paperwork. Book a demo now!
- Jurimesh — Jurimesh streamlines legal due diligence with automated red-flag detection, tailored recommendations, and detailed DD reports, empowering legal teams with insights and efficiency for every transaction.
- IntelliProve — Supercharge your digital health solution with clinically-validated biomarker data from sophisticated facial scanning technology.
Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform.
He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Turkey, Belgium
Portfolio highlights
- idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Joris Van Der Gucht - Co-founder @ Silverfin
Show more
Investment focus
- Psychology, Health Care, Health Diagnostics
- Seed, Pre-Seed
- Belgium
Portfolio highlights
- IntelliProve — Supercharge your digital health solution with clinically-validated biomarker data from sophisticated facial scanning technology.
- Predikt — Predikt empowers finance leaders to navigate today’s volatile markets with clarity and confidence. By integrating advanced AI, external market data, and internal financial metrics, Predikt transforms forecasting into a strategic advantage.Our pioneering Confidence Intelligence platform:- Provides transparency and automation to reduceforecasting uncertainty. - Enables CFOs to assess risks, identify opportunities, and align teams globally. - Turns data into decisions that foster resilience and drive growth.We understand the challenges finance leaders face: juggling a high-level view with local market complexities. That’s why Predikt is designed to enhance collaboration, challenge assumptions, and provide confidence in every number.Founded by a Swiss-Belgian team in 2023, Predikt is democratizing predictive technology, equipping finance teams to make smarter decisions and thrive amid uncertainty.
Investors by industry
Proptech
Impact
Hardware
Gaming
Google
Consumer
Energy
Climate
Marketplace
FinTech
Health Care
Community
Artificial intelligence
Biotech
EdTech
Sustainability
Venture Capital
Organic Food
Real Estate
Social Media
Web3
Big Data
Education
Finance
Android
Video Games
Payments
Publishing
Food and Beverage
Art
Financial Services
Retail
Clean Energy
Digital Media
B2B
Photography
Infrastructure
Social Network
Beauty
Platforms
Mobile Advertising
Recruiting
Franchise
Biotechnology
Hospitality
Cannabis
Construction
Fitness
Travel
Automotive
Local
Wine And Spirits
eSports
Medical Device
Crowdfunding
Social
CleanTech
Legal
Mobile Apps
Transportation
Enterprise Software
InsurTech
Enterprise
Internet
Sports
Medical
LGBT
Email
Wellness
Music
Manufacturing
Mobile
Fashion
Oil and Gas
SaaS
Theatre
Film
Life Science
Non Profit
Renewable Energy
Sporting Goods
Restaurants
Social Impact
Celebrity
Software
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
Germany
United Kingdom
India
New Zealand
Canada
Ireland
Australia
United States
South Korea
China
Oceania
Japan
Sri Lanka
Singapore
Europe
Indonesia
South Africa
Vietnam
LATAM
Spain
Armenia
Brazil
Africa
Middle East
Qatar
Asia
Georgia
Ecuador
Saudi Arabia
Bahrain
Liberia
Faroe Islands
Belize
Kuwait
Egypt
Peru
Croatia
Myanmar
Greece
Liechtenstein
Ghana
Morocco
Hungary
Norway
Finland
Mexico
Estonia
Panama
Costa Rica
Czech Republic
Lithuania
Ethiopia
France
Belgium
Nicaragua
Hong Kong
Mali
Lebanon
Mauritius
Barbados
Gibraltar
Bermuda
Philippines
Belarus
Algeria
Chile
Israel
Jersey
Denmark
Malaysia
Bulgaria
Malta
Italy
Tajikistan
Togo
Seychelles
Dominican Republic
Namibia
Poland
Iceland
Zimbabwe
Tanzania
Azerbaijan
Puerto Rico
Nigeria
Serbia
Bahamas
Sweden
Iraq
United Arab Emirates
Senegal
Taiwan
Jamaica
Honduras
Bolivia
Rwanda
Tunisia
Isle of Man
Zambia
Luxembourg
Slovenia
Sierra Leone
San Marino
Thailand
Pakistan
Uruguay
Portugal
Uzbekistan
Albania
Russian Federation
Romania
Turkey
El Salvador
Ukraine
Uganda
Grenada
Bangladesh
Venezuela
Argentina
Jordan
Kenya
Kazakhstan
Cayman Islands
Cambodia
Cyprus
Oman
Latvia
Guatemala
Cameroon
Austria
Switzerland
Colombia
Marshall Islands
Angel Investors in Belgium by industry
Biotechnology
Marketplace
Food and Beverage
Financial Services
Big Data
Finance
Life Science
Medical
Medical Device
Internet
Social Media
Manufacturing
Software
Sports
Enterprise Software
Mobile Advertising
Hospitality
Automotive
FinTech
Enterprise
Health Care
Biotech
Climate
SaaS
Community
Gaming
Real Estate
Publishing
Retail
Transportation
Platforms
Legal
Payments
Proptech
Artificial intelligence
Hardware
Media (entertainment)
Construction
Machine Learning
Energy
Mobile